ArticleClinics (Sao Paulo, Brazil)2015

Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway.

Mengguo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.